David M. Stern
236 works · 42,283 citations · h-index 94
Top works
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
- Endothelial cells in physiology and in the pathophysiology of vascular disorders.
- The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
- Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
- Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases
- The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
- Activation of Receptor for Advanced Glycation End Products
- N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
- Understanding RAGE, the receptor for advanced glycation end products
- ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
- Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
- Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
- RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
- The biology of the receptor for advanced glycation end products and its ligands
- Induction of Interleukin 6 (IL-6) by Hypoxia in Vascular Cells
- Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model
- Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices
- An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease
- Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response